Naringin acts as a TRPV1 antagonist to attenuate UVB ‐induced senescence and damage in HaCaT cells
Chemical Biology & Drug Design · 2024
DOI: 10.1111/cbdd.14390 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2024. Verfasst von Ying-Jie Zhu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology & STD, Southern University of Science and Technology Hospital, Shenzhen, Guangdong, China. Hauptthemen laut MEDLINE: HaCaT Cells, Matrix Metalloproteinase 9, Flavanones. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
This study aimed to explore the mechanism of naringin (Nar) in alleviating ultraviolet B (UVB)‐induced HaCaT cell senescence and damage. Human keratinocytes (HaCaT cells) were divided into control, UVB, UVB + Nar, UVB + Cap, and UVB + Nar + Cap groups. Analysis was performed using the MTT assay to assess cell viability, flow cytometry to measure the apoptosis level, SA‐β‐Gal staining to observe cellular senescence, and Western blot to assess protein levels of TRPV1, p16, p53, p21, matrix metalloproteinase (MMP)‐1, and MMP‐9. Both UVB irradiation and capsaicin (Cap) treatment upregulated the expression of TRPV1 in HaCaT cells, inhibited cell proliferation, promoted apoptosis, and increased the expression of p16, p53, p21, MMP‐1, and MMP‐9. Nar treatment reversed the above effects via inhibition of TRPV1 expression, thereby relieving senescence and cell damage induced by UVB irradiation. Taken together, these findings suggest that Nar can reduce UVB‐induced senescence and damage in HaCaT cells by acting as an antagonist of TRPV1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology & STD, Southern University of Science and Technology Hospital, Shenzhen, Guangdong, China.
- Department of Dermatology & STD, Guangdong Women and Children Hospital, Guangzhou, Guangdong, China.
ORCID-Profile: Ying-Jie Zhu
Zitieren
APA
Zhu, Y. J., Chen, H. L., Cai, X. J., Zhan, B. L., & Liu, X. M. (2024). Naringin acts as a TRPV1 antagonist to attenuate UVB ‐induced senescence and damage in HaCaT cells. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.14390
Vancouver
Zhu YJ, Chen HL, Cai XJ, Zhan BL, Liu XM. Naringin acts as a TRPV1 antagonist to attenuate UVB ‐induced senescence and damage in HaCaT cells. Chemical Biology & Drug Design. 2024. doi:10.1111/cbdd.14390
BibTeX
@article{Zhu2024,
author = {Zhu, Ying-Jie and Chen, Hu-Lin and Cai, Xin-Jie and Zhan, Bang-le and Liu, Xiao-Ming},
title = {Naringin acts as a TRPV1 antagonist to attenuate UVB ‐induced senescence and damage in HaCaT cells},
journal = {Chemical Biology & Drug Design},
year = {2024},
doi = {10.1111/cbdd.14390}
}
EUVIMED